{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T23:22:30Z","timestamp":1782602550172,"version":"3.54.5"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2011,5,19]],"date-time":"2011-05-19T00:00:00Z","timestamp":1305763200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Gastroenterol"],"published-print":{"date-parts":[[2011,8]]},"DOI":"10.1007\/s00535-011-0407-9","type":"journal-article","created":{"date-parts":[[2011,5,18]],"date-time":"2011-05-18T02:19:33Z","timestamp":1305685173000},"page":"1010-1019","source":"Crossref","is-referenced-by-count":17,"title":["A retrospective cohort study of partial splenic embolization for antiviral therapy in chronic hepatitis C with thrombocytopenia"],"prefix":"10.1007","volume":"46","author":[{"given":"Hiroki","family":"Tahara","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hitoshi","family":"Takagi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ken","family":"Sato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasushi","family":"Shimada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroki","family":"Tojima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoyuki","family":"Hirokawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatsuya","family":"Ohyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katsuhiko","family":"Horiuchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsushi","family":"Naganuma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hirotaka","family":"Arai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoru","family":"Kakizaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masatomo","family":"Mori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2011,5,19]]},"reference":[{"key":"407_CR1","doi-asserted-by":"crossref","first-page":"130","DOI":"10.2174\/1874467210801020130","volume":"1","author":"K Sato","year":"2008","unstructured":"Sato K, Takagi H, Ichikawa T, Kakizaki S, Mori M. Emerging therapeutic strategies for hepatitis C virus infection. Curr Mol Pharmacol. 2008;1:130\u201350.","journal-title":"Curr Mol Pharmacol"},{"key":"407_CR2","doi-asserted-by":"crossref","first-page":"105","DOI":"10.7326\/0003-4819-142-2-200501180-00009","volume":"142","author":"Y Shiratori","year":"2005","unstructured":"Shiratori Y, Ito Y, Yokosuka O, Imazeki F, Nakata R, Tanaka N, et al. Antiviral therapy for cirrhotic hepatitis C: association with reduced hepatocellular carcinoma development and improved survival. Ann Intern Med. 2005;142:105\u201314.","journal-title":"Ann Intern Med"},{"key":"407_CR3","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1053\/gast.2002.33023","volume":"122","author":"T Poynard","year":"2002","unstructured":"Poynard T, McHutchison J, Manns M, Trepo C, Lindsay K, Goodman Z, et al. Impact of pegylated interferon alfa-2b and ribavirin on liver fibrosis in patients with chronic hepatitis C. Gastroenterology. 2002;122:1303\u201313.","journal-title":"Gastroenterology"},{"key":"407_CR4","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1002\/hep.21440","volume":"44","author":"GT Everson","year":"2006","unstructured":"Everson GT, Hoefs JC, Seeff LB, Bonkovsky HL, Naishadham D, Shiffman ML, et al. Impact of disease severity on outcome of antiviral therapy for chronic hepatitis C: lessons from the HALT-C trial. Hepatology. 2006;44:1675\u201384.","journal-title":"Hepatology"},{"key":"407_CR5","doi-asserted-by":"crossref","first-page":"346","DOI":"10.7326\/0003-4819-140-5-200403020-00010","volume":"140","author":"SJ Hadziyannis","year":"2004","unstructured":"Hadziyannis SJ, Sette H Jr, Morgan TR, Balan V, Diago M, Marcellin P, et al. Peginterferon-alpha2a and ribavirin combination therapy in chronic hepatitis C: a randomized study of treatment duration and ribavirin dose. Ann Intern Med. 2004;140:346\u201355.","journal-title":"Ann Intern Med"},{"key":"407_CR6","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1172\/JCI105380","volume":"45","author":"RH Aster","year":"1966","unstructured":"Aster RH. Pooling of platelets in the spleen: role in the pathogenesis of \u201chypersplenic\u201d thrombocytopenia. J Clin Invest. 1966;45:645\u201357.","journal-title":"J Clin Invest"},{"key":"407_CR7","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/BF00168872","volume":"20","author":"Y Aoki","year":"1993","unstructured":"Aoki Y, Hirai K, Tanikawa K. Mechanism of thrombocytopenia in liver cirrhosis: kinetics of indium-111 tropolone labelled platelets. Eur J Nucl Med. 1993;20:123\u20139.","journal-title":"Eur J Nucl Med"},{"key":"407_CR8","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S0168-8278(96)80021-3","volume":"24","author":"T Nagamine","year":"1996","unstructured":"Nagamine T, Ohtuka T, Takehara K, Arai T, Takagi H, Mori M. Thrombocytopenia associated with hepatitis C viral infection. J Hepatol. 1996;24:135\u201340.","journal-title":"J Hepatol"},{"key":"407_CR9","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1016\/j.jhep.2008.03.009","volume":"48","author":"N Afdhal","year":"2008","unstructured":"Afdhal N, McHutchison J, Brown R, Jacobson I, Manns M, Poordad F, et al. Thrombocytopenia associated with chronic liver disease. J Hepatol. 2008;48:1000\u20137.","journal-title":"J Hepatol"},{"key":"407_CR10","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.gassur.2003.10.009","volume":"8","author":"KW Kercher","year":"2004","unstructured":"Kercher KW, Carbonell AM, Heniford BT, Matthews BD, Cunningham DM, Reindollar RW. Laparoscopic splenectomy reverses thrombocytopenia in patients with hepatitis C cirrhosis and portal hypertension. J Gastrointest Surg. 2004;8:120\u20136.","journal-title":"J Gastrointest Surg."},{"key":"407_CR11","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1097\/SLE.0b013e3181a6ec7c","volume":"19","author":"JH Zhu","year":"2009","unstructured":"Zhu JH, Wang YD, Ye ZY, Zhao T, Zhu YW, Xie ZJ, et al. Laparoscopic versus open splenectomy for hypersplenism secondary to liver cirrhosis. Surg Laparosc Endosc Percutan Tech. 2009;19:258\u201362.","journal-title":"Surg Laparosc Endosc Percutan Tech."},{"key":"407_CR12","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1007\/s00464-009-0744-4","volume":"24","author":"Y Wang","year":"2010","unstructured":"Wang Y, Zhan X, Zhu Y, Xie Z, Zhu J, Ye Z. Laparoscopic splenectomy in portal hypertension: a single-surgeon 13-year experience. Surg Endosc. 2010;24:1164\u20139.","journal-title":"Surg Endosc"},{"key":"407_CR13","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.1007\/s00268-009-0095-2","volume":"33","author":"MA Amin","year":"2009","unstructured":"Amin MA, el-Gendy MM, Dawoud IE, Shoma A, Negm AM, Amer TA. Partial splenic embolization versus splenectomy for the management of hypersplenism in cirrhotic patients. World J Surg. 2009;33:1702\u201310.","journal-title":"World J Surg"},{"key":"407_CR14","first-page":"1838","volume":"55","author":"HY Wang","year":"2008","unstructured":"Wang HY, Shih SC, Lin SC, Chang WS, Wang TE, Lin FJ, et al. Partial splenic embolization: 12-month hematological effects and complications. Hepatogastroenterology. 2008;55:1838\u201342.","journal-title":"Hepatogastroenterology"},{"key":"407_CR15","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1007\/s00423-002-0342-6","volume":"387","author":"B Palsson","year":"2003","unstructured":"Palsson B, Hall\u00e9n M, Forsberg AM, Alwmark A. Partial splenic embolization: long-term outcome. Langenbecks Arch Surg. 2003;387:421\u20136.","journal-title":"Langenbecks Arch Surg."},{"key":"407_CR16","first-page":"1445","volume":"49","author":"T Tajiri","year":"2002","unstructured":"Tajiri T, Onda M, Yoshida H, Mamada Y, Taniai N, Kumazaki T. Long-term hematological and biochemical effects of partial splenic embolization in hepatic cirrhosis. Hepatogastroenterology. 2002;49:1445\u20138.","journal-title":"Hepatogastroenterology"},{"key":"407_CR17","first-page":"309","volume":"43","author":"K Sakata","year":"1996","unstructured":"Sakata K, Hirai K, Tanikawa K. A long-term investigation of transcatheter splenic arterial embolization for hypersplenism. Hepatogastroenterology. 1996;43:309\u201318.","journal-title":"Hepatogastroenterology"},{"key":"407_CR18","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1002\/hep.1840180214","volume":"18","author":"B Sangro","year":"1993","unstructured":"Sangro B, Bilbao I, Herrero I, Corella C, Longo J, Beloqui O, et al. Partial splenic embolization for the treatment of hypersplenism in cirrhosis. Hepatology. 1993;18:309\u201314.","journal-title":"Hepatology."},{"key":"407_CR19","doi-asserted-by":"crossref","first-page":"2227","DOI":"10.1056\/NEJMoa073255","volume":"357","author":"JG McHutchison","year":"2007","unstructured":"McHutchison JG, Dusheiko G, Shiffman ML, Rodriguez-Torres M, Sigal S, Bourliere M, et al. Eltrombopag for thrombocytopenia in patients with cirrhosis associated with hepatitis C. N Engl J Med. 2007;357:2227\u201336.","journal-title":"N Engl J Med"},{"key":"407_CR20","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1007\/s00464-009-0653-6","volume":"24","author":"T Akahoshi","year":"2010","unstructured":"Akahoshi T, Tomikawa M, Korenaga D, Ikejiri K, Saku M, Takenaka K. Laparoscopic splenectomy with peginterferon and ribavirin therapy for patients with hepatitis C virus cirrhosis and hypersplenism. Surg Endosc. 2010;24:680\u20135.","journal-title":"Surg Endosc"},{"key":"407_CR21","first-page":"488","volume":"17","author":"K Ikezawa","year":"2010","unstructured":"Ikezawa K, Naito M, Yumiba T, Iwahashi K, Onishi Y, Kita H, et al. Splenectomy and antiviral treatment for thrombocytopenic patients with chronic hepatitis C virus infection. J Viral Hepat. 2010;17:488\u201392.","journal-title":"J Viral Hepat."},{"key":"407_CR22","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1111\/j.1872-034X.2008.00481.x","volume":"39","author":"D Morihara","year":"2009","unstructured":"Morihara D, Kobayashi M, Ikeda K, Kawamura Y, Saneto H, Yatuji H, et al. Effectiveness of combination therapy of splenectomy and long-term interferon in patients with hepatitis C virus-related cirrhosis and thrombocytopenia. Hepatol Res. 2009;39:439\u201347.","journal-title":"Hepatol Res."},{"key":"407_CR23","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1111\/j.1399-0012.2009.01081.x","volume":"24","author":"R B\u00e1rcena","year":"2010","unstructured":"B\u00e1rcena R, Moreno A, Foruny JR, Bl\u00e1zquez J, Graus J, Riesco JM, et al. Partial splenic embolization and peg-IFN plus RBV in liver transplanted patients with hepatitis C recurrence: safety, efficacy and long-term outcome. Clin Transplant. 2010;24:366\u201374.","journal-title":"Clin Transplant"},{"key":"407_CR24","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1111\/j.1872-034X.2008.00357.x","volume":"38","author":"Y Miyake","year":"2008","unstructured":"Miyake Y, Ando M, Kaji E, Toyokawa T, Nakatsu M, Hirohata M. Partial splenic embolization prior to combination therapy of interferon and ribavirin in chronic hepatitis C patients with thrombocytopenia. Hepatol Res. 2008;38:980\u20136.","journal-title":"Hepatol Res."},{"key":"407_CR25","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1111\/j.1432-2277.2006.00263.x","volume":"19","author":"N Sohara","year":"2006","unstructured":"Sohara N, Takagi H, Kakizaki S, Sato K, Mori M. The use of partial splenic artery embolization made it possible to administer interferon and ribavirin therapy in a liver transplant patient with fibrosing cholestatic hepatitis C complicated with thrombocytopenia. Transpl Int. 2006;19:255\u20137.","journal-title":"Transpl Int"},{"key":"407_CR26","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1177\/135965350400900605","volume":"9","author":"A Moreno","year":"2004","unstructured":"Moreno A, B\u00e1rcena R, Bl\u00e1zquez J, Quereda C, Gil-Grande L, S\u00e1nchez J, et al. Partial splenic embolization for the treatment of hypersplenism in cirrhotic HIV\/HCV patients prior to pegylated interferon and ribavirin. Antivir Ther. 2004;9:1027\u201330.","journal-title":"Antivir Ther."},{"key":"407_CR27","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1097\/00042737-200511000-00002","volume":"17","author":"JR Foruny","year":"2005","unstructured":"Foruny JR, Bl\u00e1zquez J, Moreno A, B\u00e1rcena R, Gil-Grande L, Quereda C, et al. Safe use of pegylated interferon\/ribavirin in hepatitis C virus cirrhotic patients with hypersplenism after partial splenic embolization. Eur J Gastroenterol Hepatol. 2005;17:1157\u201364.","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"407_CR28","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1002\/hep.20772","volume":"42","author":"AS Lok","year":"2005","unstructured":"Lok AS, Ghany MG, Goodman ZD, Wright EC, Everson GT, Sterling RK, et al. Predicting cirrhosis in patients with hepatitis C based on standard laboratory tests: results of the HALT-C cohort. Hepatology. 2005;42:282\u201392.","journal-title":"Hepatology."},{"key":"407_CR29","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1111\/j.1751-2980.2008.00356.x","volume":"10","author":"K Zhou","year":"2009","unstructured":"Zhou K, Lu LG. Assessment of fibrosis in chronic liver diseases. J Dig Dis. 2009;10:7\u201314.","journal-title":"J Dig Dis."},{"key":"407_CR30","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/S0168-8278(03)00191-0","volume":"39","author":"G Colloredo","year":"2003","unstructured":"Colloredo G, Guido M, Sonzogni A, Leandro G. Impact of liver biopsy size on histological evaluation of chronic viral hepatitis: the smaller the sample, the milder the disease. J Hepatol. 2003;39:239\u201344.","journal-title":"J Hepatol"},{"key":"407_CR31","doi-asserted-by":"crossref","first-page":"2609","DOI":"10.1056\/NEJMoa042608","volume":"352","author":"A Mangia","year":"2005","unstructured":"Mangia A, Santoro R, Minerva N, Ricci GL, Carretta V, Persico M, et al. Peginterferon alfa-2b and ribavirin for 12 vs. 24\u00a0weeks in HCV genotype 2 or 3. N Engl J Med. 2005;352:2609\u201317.","journal-title":"N Engl J Med"},{"key":"407_CR32","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1111\/j.1365-2893.2009.01182.x","volume":"17","author":"Y Inoue","year":"2010","unstructured":"Inoue Y, Hiramatsu N, Oze T, Yakushijin T, Mochizuki K, Hagiwara H, et al. Factors affecting efficacy in patients with genotype 2 chronic hepatitis C treated by pegylated interferon alpha-2b and ribavirin: reducing drug doses has no impact on rapid and sustained virological responses. J Viral Hepat. 2010;17:336\u201344.","journal-title":"J Viral Hepat."},{"key":"407_CR33","doi-asserted-by":"crossref","unstructured":"Numata M, Kagawa T, Kojima S, Hirose S, Nagata N, Shiraishi K, et al. Differential impact of adherence to pegylated interferon and ribavirin in the treatment of genotype 1 high viral titer chronic hepatitis C. Hepat Res Treat. 2010;2010:702\u201348.","DOI":"10.1155\/2010\/702748"},{"key":"407_CR34","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1007\/s00535-009-0087-x","volume":"44","author":"T Okanoue","year":"2009","unstructured":"Okanoue T, Itoh Y, Hashimoto H, Yasui K, Minami M, Takehara T, et al. Predictive values of amino acid sequences of the core and NS5A regions in antiviral therapy for hepatitis C: a Japanese multi-center study. J Gastroenterol. 2009;44:952\u201363.","journal-title":"J Gastroenterol"},{"key":"407_CR35","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1038\/ng.449","volume":"41","author":"Y Tanaka","year":"2009","unstructured":"Tanaka Y, Nishida N, Sugiyama M, Kurosaki M, Matsuura K, Sakamoto N, et al. Genome-wide association of IL28B with response to pegylated interferon-alpha and ribavirin therapy for chronic hepatitis C. Nat Genet. 2009;41:1105\u20139.","journal-title":"Nat Genet"},{"key":"407_CR36","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1002\/bjs.6081","volume":"95","author":"H Hayashi","year":"2008","unstructured":"Hayashi H, Beppu T, Okabe K, Masuda T, Okabe H, Baba H. Risk factors for complications after partial splenic embolization for liver cirrhosis. Br J Surg. 2008;95:744\u201350.","journal-title":"Br J Surg"},{"key":"407_CR37","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.dld.2008.10.005","volume":"41","author":"K Zhu","year":"2009","unstructured":"Zhu K, Meng X, Qian J, Huang M, Li Z, Guan S, et al. Partial splenic embolization for hypersplenism in cirrhosis: a long-term outcome in 62 patients. Dig Liver Dis. 2009;41:411\u20136.","journal-title":"Dig Liver Dis."}],"container-title":["Journal of Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00535-011-0407-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00535-011-0407-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00535-011-0407-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,6]],"date-time":"2024-04-06T20:10:54Z","timestamp":1712434254000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00535-011-0407-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,5,19]]},"references-count":37,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2011,8]]}},"alternative-id":["407"],"URL":"https:\/\/doi.org\/10.1007\/s00535-011-0407-9","relation":{},"ISSN":["0944-1174","1435-5922"],"issn-type":[{"value":"0944-1174","type":"print"},{"value":"1435-5922","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,5,19]]}}}